Tango Therapeutics's total assets for Q2 2024 were $381.45M, a decrease of -6.10% from the previous quarter. TNGX total liabilities were $133.78M for the fiscal quarter, a -5.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.